CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Mepilex Border Post-Op Agdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03016078
NCT03016078N/ACompleted
CompareCT.gov

A Single Center, Open, Non-controlled Investigation to Evaluate the Performance of a Flexible, Self-adherent Absorbent Silver Dressing Coated With a Soft Silicone Layer After Elective Primary Total Hip or Knee Arthroplasty

Molnlycke Health Care AB·interventional·Posted Jan 10, 2017·Updated Feb 14, 2018

In Brief

A clinical study evaluating Mepilex Border Post-Op Ag for Arthroplasties, Hip Replacement and Arthroplasties, Knee Replacement. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The overall rationale for this investigation is to evaluate the clinical performance potential for Mepilex Border Post-Op Ag in the ability to minimize the risk of skin related post-operative wound complications such as blistering, maceration and redness at the incision and surrounding skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasties, Hip Replacement, Arthroplasties, Knee Replacement
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 10, 2017
Enrollment StartFeb 1, 2017
Primary CompletionApr 1, 2017
Study CompletionApr 7, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.5 years ago

Interventions

Mepilex Border Post-Op Agdevice

To investigate if there was any skin damage under the dressing from operation day to last visit.